Heart Surgery

Latest Issue of OR Manager
January 2025
Home Surgery/Specialties > Heart Surgery

FDA: Abbott issues safety notice for MitraClip Delivery System

Editor's Note The Food and Drug Administration on February 29 announced a safety notice issued by Abbott (Abbott Park, Illinois) to reinforce the proper procedures used to operate and deploy its MitraClip Delivery System. The company has received nine reports of device malfunction where the user was unable to separate…

Read More

By: Judy Mathias
March 2, 2016
Share

New guidelines recommend use of arterial grafts for coronary bypass

Editor's Note New clinical practice guidelines from the Society of Thoracic Surgeons recommend the use of arteries from the chest and forearm rather than using veins from the leg for coronary artery bypass grafting. The left internal thoracic artery is considered the gold standard conduit for coronary bypass and has…

Read More

By: Judy Mathias
December 8, 2015
Share

FDA: Boston Scientific recalls RotaWire Elite and wireClip Torquer Guidewires

Editor's Note Boston Scientific Corporation is recalling RotaWire Elite core wires because they may crack and separate from the rest of the Rotablator Rotational Atherectomy System and cause serious injury such as tamponade, myocardial infarction, and migration of wire fragments, the Food and Drug Administration reported November 27. Boston Scientific…

Read More

By: Judy Mathias
November 30, 2015
Share

Ultrasound-guided vs angiography-guided coronary stent implantation

Editor's Note In patients requiring long coronary stents, the use of intravascular ultrasound (IVUS)-guided vs angiography-guided drug-eluting stent implantation resulted in a significantly lower rate (2.9% absolute reduction, 48% relative reduction) of major adverse cardiac events at 1 year, finds this study. These differences were mainly driven by the reduction…

Read More

By: Judy Mathias
November 11, 2015
Share

Sponsored Message

Appropriate use criteria reduces nonacute, inappropriate PCIs

Editor's Note Since publication of the Appropriate Use Criteria for Coronary Revascularization in 2009, the number of nonacute percutaneous coronary interventions (PCIs) has declined significantly (89,704 vs 59,375). The proportion of nonacute PCIs classified as inappropriate has also declined (26.2% vs 13.3%), although hospital-level variation persists. These findings indicate that…

Read More

By: Judy Mathias
November 10, 2015
Share

FDA: Quest Medical recalls certain lots of Myocardial Protection System delivery sets

Editor's Note Quest Medical, Inc (Allen, Texas), on October 28 initiated a nationwide recall of its Myocardial Protection System delivery sets, Models 5001102, 5001102-AS, and 7001102 of specified lots. The sets have shown possible seal failure along the blood source channel of the main pump cassette, resulting in blood loss…

Read More

By: Judy Mathias
November 3, 2015
Share

Sponsored Message

Marital status linked to better outcomes after cardiac surgery

Editor's Note Compared to married patients, those who were divorced, separated, or widowed had a 40% greater chance of dying or developing a functional disability in the first 2 years after cardiac surgery, in this study. Characterizing the association between marital status and postoperative function may be useful for counseling…

Read More

By: Judy Mathias
October 29, 2015
Share

FDA safety alert: Heater-cooler devices linked to infections

Editor's Note The Food and Drug Administration on October 15 issued a safety alert that heater-cooler devices have been associated with Nontuberculous Mycobacteria infections, primarily in patients undergoing cardiothoracic surgical procedures. Devices include: oxygenator heat exchangers cardioplegia heat exchangers warming/cooling blankets. Between January 2010 and August 2015, the FDA received…

Read More

By: Judy Mathias
October 19, 2015
Share

OR leaders discuss hybrid ORs at OR Manager Conference Town Hall

A highlight of this year’s OR Manager Conference in Nashville, Tennessee, was an interactive hybrid OR exhibit with products from 15 companies. During a special Town Hall on Thursday, October 8, members of the Hybrid OR Steering Committee answered questions from conference attendees seeking information about what’s involved in planning…

Read More

By: Judy Mathias
October 8, 2015
Share

TAVR is safe, effective in nonagenarians

Editor's Note Patients age 90 years and older with aortic stenosis can benefit from transcatheter aortic valve replacement (TAVR), this study finds. TAVR patients had a comparable risk of mortality as those who did not have the procedure, and quality of life improved within 6 months.  

Read More

By: OR Manager
September 2, 2015
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat